Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
24.20
-0.19 (-0.78%)
At close: Feb 27, 2026, 4:00 PM EST
24.68
+0.48 (1.98%)
After-hours: Feb 27, 2026, 7:18 PM EST
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $1.9 billion as of February 27, 2026. Its market cap has increased by 391.45% in one year.
Market Cap
1.90B
Enterprise Value
1.58B
1-Year Change
391.45%
Ranking
Category
Stock Price
$24.20
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has increased from $1.79B to $1.90B, an increase of 6.07%. That is a compound annual growth rate of 1.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 1.92B | -2.44% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soleno Therapeutics | 2.05B |
| Celldex Therapeutics | 2.04B |
| Stoke Therapeutics | 2.03B |
| Recursion Pharmaceuticals | 1.99B |
| Nuvation Bio | 1.99B |
| Vericel | 1.91B |
| Nektar Therapeutics | 1.84B |
| Aurinia Pharmaceuticals | 1.84B |